CVS Health (CVS Health) Risk Assessment

View and export this data going back to 1952. Start your Free Trial

What is CVS Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of CVS Health is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of CVS Health's Risk Assessment

For the Healthcare Plans subindustry, CVS Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CVS Health's Risk Assessment Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where CVS Health's Risk Assessment falls into.

CVS Health (NYSE:CVS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

CVS Health Risk Assessment Related Terms

Thank you for viewing the detailed overview of CVS Health's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

CVS Health (CVS Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (NYSE:CVS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

CVS:Peru CVS:Mexico 1CVS:Italy CVSd:UK CVS0:Germany CVS:Germany CVS:Germany CVS:Germany CVS:Chile CVS:Canada CVSH34:Brazil CVS:Austria

Address

One CVS Drive, Woonsocket, RI, USA, 02895

Website

https://www.cvshealth.com

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

Executives

Edward J Ludwig	director	C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Michael F Mahoney	director	BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Thomas F. Cowhey	officer: SVP, Interim CFO	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
J Scott Kirby	director	233 S. WACKER DRIVE 11TH FL WHQLD, CHICAGO IL 60606
Brian A Kane	officer: EVP/President, Aetna	500 W MAIN STREET, LOUISVILLE KY 40202
James David Clark	officer: SVP, Cont & Chief Acct Officer	ONE CVS DRIVE, WOONSOCKET RI 02760
Karen S Lynch	officer: EVP & Pres, Aetna Bus Unit	151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Samrat S. Khichi	officer: EVP, CPO and General Counsel	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Thomas M Moriarty	officer: EVP & General Counsel	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey R. Balser	director	3657 RICHLAND AVE., NASHVILLE TN 37205
Alan Lotvin	officer: EVP, Transformation	55 NOD ROAD, AVON CT 06001
Daniel P Finke	officer: EVP/Pres, Health Care Benefits	ONE CVS DRIVE, WOONSOCKET RI 02895
Tilak Mandadi	officer: EVP, Chief Technology Officer	3600 LAS VEGAS BLVD. SOUTH, LAS VEGAS NV 89109
Sreekanth K Chaguturu	officer: EVP and Chief Medical Officer	ONE CVS DRIVE, WOONSOCKET RI 02895
Prem S Shah	officer: EVP and Co-President of Retail	ONE CVS DRIVE, WOONSOCKET RI 02895